News & Events

News


Tuesday June 16, 2020

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders

Strategic partnership agreement provides Neurocrine Biosciences exclusive worldwide rights to early-to-mid-stage psychiatry pipeline compounds within Takeda’s Neuroscience portfolio Collaboration includes three clinical-stage assets with the most advanced molecule in Phase II for negative symptoms


Monday June 15, 2020

Neurocrine Biosciences to Present at the Bank of America Securities 2020 Napa Biopharma Conference

Live Webcast will be on June 22, 2020 SAN DIEGO , June 15, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT ( 5:00 p.m. ET ) on Monday, June 22, 2020 .


Monday June 08, 2020

Neurocrine Biosciences Reports Positive Phase II Data for Crinecerfont in Adults with Congenital Adrenal Hyperplasia at ENDO Online 2020

In the news release, Neurocrine Biosciences Reports Positive Phase II Data for Crinecerfont in Adults with Congenital Adrenal Hyperplasia at ENDO Online 2020, issued 08-Jun-2020 by Neurocrine Biosciences, Inc. over PR Newswire, we are advised by the company that the first paragraph, last sentence,


Thursday June 04, 2020

Neurocrine Biosciences to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast

Live Webcast will be on June 11, 2020 SAN DIEGO , June 4, 2020 /PRNewswire/ --  Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 41 st Annual Global Healthcare Conference Webcast at 9:40 a.m. ET on Thursday, June 11, 2020 .


Friday May 29, 2020

FDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women

- Uterine fibroids are the most common type of benign tumor in women of reproductive age[1] - ORIAHNN™ (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) is expected to be available in the U.S. by the end of June 2020 NORTH CHICAGO, Ill.

Events